Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01155609 · ClinicalTrials.gov registry record · NA
L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT01155609 is a NA study that has completed, run by University of Washington. The registered enrollment target is 10 participants.
The verdict
NCT01155609, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This pilot clinical trial studies L-lysine in treating oral mucositis in patients undergoing radiation therapy with or without chemotherapy for head and neck cancer. L-lysine may lessen the severity of oral mucositis, or mouth sores in patients receiving radiation therapy with or without chemotherapy for head and neck cancer
Interventions
- PROCEDURE quality-of-life assessment
- PROCEDURE management of therapy complications
- DIETARY_SUPPLEMENT L-lysine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2010-09 |
| Est. Completion | 2012-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01155609
The ClinicalTrials.gov registry entry for NCT01155609 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which quality-of-life assessment is the first listed.
NCT01155609 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01155609 about?
NCT01155609 is a clinical study titled "L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer". This pilot clinical trial studies L-lysine in treating oral mucositis in patients undergoing radiation therapy with or without chemotherapy for head and neck cancer. L-lysine may lessen the severity of oral mucositis, or mouth sores in patients receiving radiation therapy with or without chemotherap...
What is the current status of trial NCT01155609?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2010-09. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01155609?
The interventions under investigation include: quality-of-life assessment (PROCEDURE), management of therapy complications (PROCEDURE), L-lysine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01155609?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.